1. |
Tallstedt L, Lundall G, Torring O, et al. Occurrence of ophthalmopathy aftertreatment for Graves’ hyperthyroidism[J]. N Engl J Med, 1992, 326(26): 1733-1738.
|
2. |
Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy[J]. N Engl J Med, 1998, 338(2): 73-78.
|
3. |
Kung AW, Yau CC, Cheng A. The incidence of ophthalmopathy after radioiodine therapy for Graves’ disease: prognostic factors and the role of methimazole[J]. J Clin Endocrinol Metab, 1994, 79(2): 542-546.
|
4. |
Perros P, Kendall-Taylor P, Neoh C, et al. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves’ ophthalmopathy[J]. J Clin Endocrinol Metab, 2005, 90(9): 5321-5323.
|
5. |
中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南—甲状腺功能亢进症[J]. 中华内科杂志, 2007, 46(10):876-882.
|
6. |
Bartley GB, Corman CA. Diagnostic criteria for Graves’ ophthalmopathy[J]. Am J Ophthahnol, 1995, 119(6): 792-795.
|
7. |
曹明明, 童南伟. Graves眼病的诊断和治疗[J]. 内科理论与实践, 2010, 5(2): 177-179.
|
8. |
James CS, Matthew JS, Christine CN, et al. Radioiodine therapy and Graves’ Ophthalmopathy[J]. J Nucl Med, 2008, 49(6): 923-930.
|
9. |
Vannucchi G, Campi I, Covelli D, et al. Graves’ orbitopathy activation after radioactive Iodine therapy with and without steroid prophylaxis[J]. J Clin Endocrinol Metab, 2009, 94(9): 3381-3386.
|
10. |
Bałdys-Waligórska A, Gołkowski F, Kusnierz-Cabala B, et al. Graves’ ophthalmopathy in patients treated with radioiodine 131-I[J]. Endokrynol Pol, 2011, 62(3): 214-219.
|
11. |
Crisp MS, Lane C, Halliwell M, et al. Thyrotropin receptor transcripts in humadipose tissue[J]. J Clin Endocrinol Metab, 1997, 82(6): 2003-2005.
|
12. |
Feliciello A, Porcellini A, Ciullo I, et al. Expression of thyrotropin-receptor mRNA in healthy and Graves’ disease retro-orbital tissue[J]. Lancet, 1993, 342(8867): 337-338.
|
13. |
Boschi A, Daumerie Ch, Spiritus M, et al. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy[J]. Br J Ophthalmol, 2005, 89(6): 724-729.
|
14. |
宋补昌, 李宝兰, 孙斌. 血清TRAb检测对Graves’病突眼的应用价值[J]. 放射免疫学杂志, 2005, 18(6): 478-479.
|
15. |
唐武儒, 韦南仕. TRAb 水平测定在甲亢并突眼治疗中的意义探讨[J]. 右江民族医学院学报, 2006, 28(1): 56-56.
|
16. |
王亚萍, 肖锦华, 朱华燕, 等. 全自动电化学发光免疫分析法检测血清TRAb的方法学评价[J]. 放射免疫学杂志, 2011, 24(6): 661-664.
|
17. |
Subekti I, Boedisantoso A, Moeloek ND, et al. Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy[J]. Acta Med Indones, 2012, 44(2): 114-121.
|
18. |
何建华, 曾钦文. TSH受体抗体及临床意义[J]. 国外医学·放射医学核医学分册, 2001, 25(3): 111-114.
|